Literature DB >> 7026594

Endogenous hydrocortisone, a possible factor contributing to the genesis of cushingoid habitus in patients on prednisone.

F J Frey, W J Amend, F Lozada, B M Frey, L Z Benet.   

Abstract

To establish if the cushingoid habitus in patients taking prednisone is associated with relatively high total or free prednisolone and low endogenous hydrocortisone concentrations in plasma, 15 stable renal transplant patients and 12 patients treated with prednisone for oral mucocutaneous vesiculo-erosive diseases were investigated. After the patients' usual prednisone doses, the areas under the plasma concentration time curve of total and free prednisolone were not different when the 14 patients without cushingoid appearance were compared to the 13 patients with cushingoid appearance. Patients with cushingoid habitus more frequently exhibited peak hydrocortisone levels within the normal range (6 of 14 vs. 1 of 13) and had higher areas under the plasma concentration time curve of hydrocortisone (median, range), i.e. 2672 ng/ml.min (0-21, 637 ng/ml.min) vs. 308 ng/ml.min (0-12, 495 ng/ml.min) compared to those without cushingoid appearance (P less than 0.05). These results indicate that pharmacokinetic differences of prednisone do not explain the presence or absence of cushingoid habitus and that there is an association between cushingoid habitus and endogenous hydrocortisone levels.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7026594     DOI: 10.1210/jcem-53-5-1076

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Steroid metabolism in liver transplant patients.

Authors:  R Venkataramanan; M L Huang; B Delamos; G J Burckart; R J Ptachcinski; D H Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

Review 2.  Clinical pharmacokinetics of prednisone and prednisolone.

Authors:  B M Frey; F J Frey
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

3.  Pharmacokinetics of prednisolone in children with the nephrotic syndrome.

Authors:  M Rostin; P Barthe; G Houin; M Alvinerie; F Bouissou
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

4.  Intra-individual consistency of prednisolone kinetics during long-term prednisone treatment.

Authors:  E Langhoff; H Flachs; J Ladefoged; E F Hvidberg
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Clinical value of assessing prednisolone pharmacokinetics before and after renal transplantation.

Authors:  L Ost; I Björkhem; C von Bahr
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Pharmacokinetic interaction of contraceptive steroids with prednisone and prednisolone.

Authors:  B M Frey; H J Schaad; F J Frey
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  The effect of prednisone and hydrocortisone on the plasma protein binding of prednisolone in man.

Authors:  U F Legler; L Z Benet
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.